Abstract
The primary aim of the present study was to test the hypothesis that amino acid transport systems are involved in absorptive transport of dicysteinylmercury (cysteine-Hg-cysteine). Luminal disappearance flux [JD, fmol min−1 (mm tubular length)−1] of inorganic mercury (Hg2+), in the form of dicysteinylmercury, was measured in isolated perfused S2 segments with various amino acids or amino acid analogs in the luminal compartment under one of two conditions, in the presence or absence of Na+. The control perfusion fluid contained 20 μM dicysteinylmercury. Replacing Na+ in both the bathing and perfusing solutions withN-methyl-d-glucamine reduced theJD of Hg2+ by about 40%. Nine amino acids and two amino acid analogs were coperfused individually (at millimolar concentrations) with dicysteinylmercury. The amino acids and amino acid analogs that had the greatest effect on theJD of Hg2+ werel-cystine, l-serine, l-histidine,l-tryptophan, and 2-(−)-endoamino-bicycloheptane-2-carboxylic acid. The greatest reduction (76%) in the total JD of Hg2+ occurred when l-cystine was coperfused with dicysteinylmercury in the presence of Na+. Overall, the current findings indicate that Hg2+ is transported from the lumen into proximal tubular epithelial cells via amino acid transporters that recognize dicysteinylmercury. In addition, the data indicate that multiple amino acid transporters are involved in the luminal uptake of dicysteinylmercury, including the Na+-dependent low-affinity l-cystine, B0, and ASC systems and the Na+-independent L-system. Furthermore, the transport data obtained whenl-cystine was added to the luminal fluid indicate strongly that dicysteinylmercury is likely transported as a molecular homolog ofl-cystine.
Footnotes
-
This study was supported by grants from the National Institutes of Environmental Health Sciences (ES 05980 to R.K.Z. and D.W.B. and ES 05157 to R.K.Z.). Vernon Cannon was supported by a graduate student minority supplement to Grant ES05157 awarded by the National Institutes of Environmental Health Sciences.
- Abbreviations:
- MeAIB
- α-methylamino-isobutyric acid
- BCH
- 2-(−)-endoamino-bicycloheptane-2-carboxylic acid
- JD
- luminal disappearance flux, fmol min−1 (mm tubular length)−1
- APM
- artificial perfusion medium
- Received November 20, 2000.
- Accepted April 17, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|